Sex differences in adverse events in Medicare individuals ≥ 66 years of age post glioblastoma treatment.
Saved in:
| Title: | Sex differences in adverse events in Medicare individuals ≥ 66 years of age post glioblastoma treatment. |
|---|---|
| Authors: | Dmukauskas M; Trans Divisional Research Program, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA., Cioffi G; Trans Divisional Research Program, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA., Waite KA; Trans Divisional Research Program, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA., Sloan AE; Neuroscience Service Line and Piedmont Brain Tumor Center, Piedmont Health, Atlanta, GA, USA., Neff C; Department of Neurosurgery, Duke University School of Medicine, Durham, NC, USA., Price M; Department of Neurosurgery, Duke University School of Medicine, Durham, NC, USA., Ostrom QT; Department of Neurosurgery, Duke University School of Medicine, Durham, NC, USA.; The Preston Robert Tisch Brain Tumor Center, Duke University School of Medicine, Durham, NC, USA., Barnholtz-Sloan JS; Trans Divisional Research Program, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA. jill.barnholtz-sloan@nih.gov.; Center for Biomedical Informatics and Information Technology, National Cancer Institute, Shady Grove Campus 9609 Medical Center Dr, 20850, Rockville, MD, USA. jill.barnholtz-sloan@nih.gov. |
| Source: | Journal of neuro-oncology [J Neurooncol] 2024 May; Vol. 168 (1), pp. 111-123. Date of Electronic Publication: 2024 Apr 02. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Country of Publication: United States NLM ID: 8309335 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7373 (Electronic) Linking ISSN: 0167594X NLM ISO Abbreviation: J Neurooncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
